Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
A Phase 2 Study to Evaluate the Efficacy and Safety of Adoptive Transfer of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Uveal Melanoma
Sponsor: Udai Kammula
Listed as NCT03467516, this PHASE2 trial focuses on Melanoma, Uveal and Uveal Neoplasms and remains actively recruiting participants. Sponsored by Udai Kammula, it has been updated 15 times since 2018, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
15 versions recorded-
Aug 2025 — Present [monthly]
Recruiting PHASE2
-
Sep 2024 — Aug 2025 [monthly]
Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE2
-
Jul 2023 — Jul 2024 [monthly]
Recruiting PHASE2
-
Sep 2022 — Jul 2023 [monthly]
Recruiting PHASE2
▶ Show 10 earlier versions
-
Jun 2022 — Sep 2022 [monthly]
Recruiting PHASE2
-
May 2022 — Jun 2022 [monthly]
Recruiting PHASE2
-
May 2021 — May 2022 [monthly]
Recruiting PHASE2
-
Jan 2021 — May 2021 [monthly]
Recruiting PHASE2
-
Mar 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
Feb 2019 — Mar 2020 [monthly]
Recruiting PHASE2
-
Sep 2018 — Feb 2019 [monthly]
Recruiting PHASE2
-
Jun 2018 — Sep 2018 [monthly]
Recruiting PHASE2
-
May 2018 — Jun 2018 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Apr 2018 — May 2018 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Udai Kammula
For direct contact, visit the study record on ClinicalTrials.gov .